Synthesis and Antitussive Effect of New Hydantoin Compounds

doi:10.1007/s40242-012-2064-9

Abstract

Abstract:

A series of new hydantoin compounds was synthesized with 3-bromo phenylacetic acid and 3,4-dimethylbromobenzene as starting material, 7-bromo-2-tetralone and 2-bromo-5,6,8,9-tetrahydro-7-benzocyclo- heptenone as intermediate and Ullmann reaction, Suzuki reaction and Bucherer-Berg's reaction as key steps. The structures of the key intermediate and target compounds were confirmed by ¹H NMR, ¹³C NMR, IR and MS. Bioactivity research showed that target compounds 6a, 6c, 6d, 6e and 15i had significant antitussive effect on the ammonia-induced cough of mice.

Key words: Hydantoin, 2-Bromo-5,6,8,9-tetrahydro-7-benzocycloheptenone, Bioactivity, 7-Bromo-2-tetralone, Antitussive effect

ZHANG Qun-li, SONG Li-jun, WANG En-si. Synthesis and Antitussive Effect of New Hydantoin Compounds[J]. Chemical Research in Chinese Universities, 2013, 29(1): 76-81.

References

[1] Liu J. M., Zhao Y., Chinese Journal of Disinfection, 2001, 18, 218

[2] Chen Q., Li Q. L., Journal of Fujian Agriculture and Forestry University(Natural Science Edition), 2003, 32, 225

[3] Chen R. F., Xue G. B., Gu C. Y., Li H., Chinese Journal of Disease Control & Prevention, 2001, 5, 15

[4] Zhang S. L., Xu Z. X., Huang J. X., Chen Z. X., Journal of Hubei University(Natural Science Edition), 2002, 24, 63

[5] Li Q. L., Lin X. H., Journal of Fujian Medical University, 2001, 35, 176

[6] Launay M., Potin D., Maillet M. J. B., Nicolai E. A., Dhar T. G. M., Iwanowicz E. J., Hydantoin Compounds Useful as Anti-inflammatory Agents, US 2002/0143035 A1, 2002

[7] Murali D. T. G., Potin D., Maillet M. J. B., Launay M., Nicolai E. A., Iwanowicz E. J., Spiro-Hydantoin Compounds Useful as Anti-inflammatory Agents, US 2004/0009998 A1, 2004

[8] Wang Y. S., 1-Methyl-Hydantoin Preparation in Application of Relieving Cough, Asthma and Phlegm Drugs. CN 1813717A, 2006

[9] Kurono M., Unno R., Kimura H., Tomiya N., Sawai K., Miura K., Usui T., Kondo Y., Tanaka Y., Nakamura S., Suzuki T., Hayashi M., Hydantoin Derivatives for Treating Complications of Diabetes and Circulatory Diseases, US 5164391, 1992

[10] Goodnow JR. R. A., Le K., Hydantoin-containing Glucokinase Activators, US 2003/0225286 A1, 2003

[11] Sun Q., Kyle D. J., Aryl Substituted Hydantoin Compounds and Their Use as Sodium Channel Blockers, US 2004/0097569 A1, 2004

[12] Mikami H., Ienage K., Method for Preventing or Treating Renal Failure, US 5084473, 1992

[13] Yang B., Liu D., Li C. Z., Liu F. Y., Peng Y. M., Jiang Y. S., Renal Failure, 2007, 29, 1025

[14] Chen D. G., Adjustment Androgen Acceptor Qctive Hydantoin Derivative Composition and Application, CN 200610067719.2, 2007

[15] Liang T., Lu H. B., Xu Z. B., Mi H. Y., Wu P. F., Cui L., Wang E. S., Journal of Jilin University(Science Edition), 2008, 46, 139

[16] Xu Z. B., Lu H. B., Liang Y. T., Liang T., Wang E. S., Journal of Jilin University(Science Edition), 2008, 46, 351

[17] Wang E. S., Liang T., Lu H. B., Mi H. Y., Synthesis and Immunosuppressive Activity of New Amino Alcohol Derivatives, CN 101768086, 2010

[18] Cui L. L., Zhang Q. L., Mi H. Y., Wang E. S., Journal of Jilin University(Science Edition), 2010, 48, 860

[19] Mi H. Y., Cui L. L., Zhang Q. L., Li F., Jiang T., Liang Y. T., Wang E. S., Chem. Res. Chinese Universities, 2011, 27(4), 614

[20] Cui L. L., Mi H. Y., Zhang Q. L., Wang W. W., Yang L. J., Liang Y. T., Wang E. S., Chem. Res. Chinese Universities, 2011, 27(5), 808